Thyssenkrupp nucera achieved earnings before interest and taxes (EBIT) of approximately 2 million euros based on preliminary figures for the 2024/25 fiscal year. In the previous year, the company had reported a negative EBIT of -14 million euros. Revenue slightly decreased to 845 million euros (previous year: 862 million euros), remaining below the original forecast of 850 to 920 million euros. However, EBIT was in the upper half of the expected range of –7 to 7 million euros. Free cash flow was positive, and the company continues to finance itself from operating activities.
Green Hydrogen Segment: Improved Results, Order Intake Collapses
In the Green Hydrogen (gH2) segment, which relies on Alkaline Water Electrolysis (AWE) for the production of climate-neutral hydrogen, revenue fell to 459 million euros (previous year: 524 million euros). EBIT improved significantly to –56 million euros from –76 million euros in the previous year. However, order intake in the gH2 segment collapsed massively: it was only 26 million euros, compared to 356 million euros in the previous year.
Chlor-Alkali Segment with Growth
The Chlor-Alkali (CA) segment developed steadily. Revenue increased to 386 million euros (previous year: 338 million euros). EBIT was slightly below the previous year's value at 58 million euros, compared to 62 million euros. Order intake in the CA segment rose to 322 million euros (previous year: 279 million euros).
Outlook 2025/26: Significant Decline Expected
For the current fiscal year 2025/26, thyssenkrupp nucera expects a revenue decline to 500 to 600 million euros. EBIT is expected to be between –30 million and 0 euros. The company cites the continued reluctance to invest in the green hydrogen market and generally deteriorating economic conditions as reasons.
CEO Werner Ponikwar explains: "The situation in the green hydrogen market has become even more challenging in the reporting year. The reluctance to make final investment decisions continues. Additionally, global economic conditions have deteriorated." To counteract this, measures have been initiated to cushion the lower cost coverage. "Thanks to our very good positioning in the hydrogen and chlor-alkali market and our very high financial resilience, we can and will overcome the challenges and continue to successfully pursue our strategic goals."
Order Backlog Significantly Decreased
Total order intake in the 2024/25 fiscal year amounted to 348 million euros (previous year: 636 million euros). The order backlog as of September 30, 2025, was 600 million euros, down from 1.1 billion euros in the previous year.
Note: All published figures and statements are preliminary and unaudited. The detailed Q4/FY 2024/2025 results as well as the revenue and earnings forecast for the group and segments for the 2025/2026 fiscal year will be published with the 2024/2025 annual report on December 17, 2025, at 07:00 CET.
